Press Release 858 Therapeutics Announces FDA Fast Track Designation for PARG Inhibitor ETX-19477 for the Treatment of Patients with BRCA-Mutated, HR+/HER2- Unresectable or Metastatic Breast Cancer 1 hour ago
Press Release RockRose Risk Raises $12.5 Million Series A to Scale Vertically Integrated Wildfire-Focused Insurance Platform 1 hour ago
Press Release The O.H.I.O. Fund Announces Lead Investment in Sonic Fire Tech’s Seed Round; Khosla Ventures Reinvests, Capping Cleveland Startup’s Seed Funding at $15M 1 hour ago
Press Release 858 Therapeutics Announces FDA Fast Track Designation for PARG Inhibitor ETX-19477 for the Treatment of Patients with BRCA-Mutated, HR+/HER2- Unresectable or Metastatic Breast Cancer 1 hour ago
Press Release Enveda Reports Positive Phase 1 Results for ENV-308, the First Pill Designed From the Chemistry of Exercise 1 hour ago
Press Release Skanska Announces Promotion of Anubhav Bhargava to Executive Vice President and General Manager 2 hours ago
Press Release NTx Bio Powers Baylor College of Medicine’s Manufacturing of a Personalized Cancer Vaccine in Diakonos Oncology’s Phase 1 Refractory Melanoma Trial 2 hours ago
Press Release Abnormal AI and OpenAI Partner to Accelerate Secure Enterprise AI Adoption and Strengthen Cyber Defense 2 hours ago
Press Release IKS Health Implements Scribble Select, an Ambient Scribe Interface, at Western Washington Medical Group 2 hours ago